Sept 2022, automated full molecular cervical cancer screening presented at the ESCV

June 2022, NEW DATA – Methylation performance in pregnant women with CIN3

May 2022, New publication on prognostic value of QIAsure/ PreCursor-M+ Methylation Test for clinical regression of disease

April 2022, NeuMoDx HPV Assay Fulfills the International Guidelines for HPV screening

April 2022, Improved testing method for cervical cancer detection: automated and patient-friendly

November 2021, QIAsure Methylation Test can decrease clinically non relevant colposcopy referrals of hpv positive women with asc-us/ lsil cytology.